Growth Metrics

Innoviva (INVA) Other Operating Expenses (2018 - 2025)

Innoviva filings provide 7 years of Other Operating Expenses readings, the most recent being $4.3 million for Q3 2025.

  • On a quarterly basis, Other Operating Expenses changed N/A to $4.3 million in Q3 2025 year-over-year; TTM through Dec 2025 was $4.3 million, a N/A change, with the full-year FY2022 number at -$60.6 million, up 13.67% from a year prior.
  • Other Operating Expenses hit $4.3 million in Q3 2025 for Innoviva, up from -$51.3 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $62.1 million in Q2 2022 to a low of -$258.7 million in Q3 2022.
  • Median Other Operating Expenses over the past 4 years was $3.6 million (2023), compared with a mean of -$25.0 million.
  • Biggest five-year swings in Other Operating Expenses: plummeted 803.79% in 2022 and later skyrocketed 80.16% in 2023.
  • Innoviva's Other Operating Expenses stood at -$28.6 million in 2021, then plummeted by 803.79% to -$258.7 million in 2022, then skyrocketed by 80.16% to -$51.3 million in 2023, then skyrocketed by 108.32% to $4.3 million in 2025.
  • The last three reported values for Other Operating Expenses were $4.3 million (Q3 2025), -$51.3 million (Q3 2023), and $36.7 million (Q2 2023) per Business Quant data.